GI Health
|
April 20, 2023

Top Intestinal Inflammatory Biomarkers Commonly Used In Functional Medicine

Written By
Dr. Jaime Cloyd ND
Medically Reviewed by
Updated On
January 14, 2025

Inflammatory bowel disease involves processes that affect the gastrointestinal tract, which can lead to uncomfortable symptoms and ongoing inflammation. It's important to differentiate these symptoms from other non-inflammatory gastrointestinal issues. Diagnostic evaluation often includes checking for intestinal inflammatory biomarkers, which can help in understanding the activity and severity of the condition.

[signup]

What is Inflammatory Bowel Disease (IBD)?

IBD is a long-term condition affecting the digestive system, marked by repeated episodes of inflammation. This can sometimes lead to changes in the intestines and other health challenges over time. IBD affects many people, and its occurrence is increasing.

Crohn's disease (CD) and ulcerative colitis (UC) are the two main types of IBD. They differ in where and how deeply they affect the digestive tract. CD can affect any part of the digestive tract with patchy areas of inflammation, while UC typically affects the innermost layer of the colon, starting from the rectum.

IBD Symptoms

IBD symptoms can come and go, with periods of discomfort followed by times of relief. Common symptoms during flare-ups include stomach pain, changes in bowel habits, and diarrhea with blood. Sometimes, inflammation can also cause symptoms in other parts of the body, like fever or joint pain.

People with CD affecting the small intestine might not absorb nutrients well, which can lead to weight loss and nutrient deficiencies.

If IBD is not well-managed, it might contribute to other health issues over time, such as:

  • Anal fistulas
  • Arthritis
  • Blood clots
  • Colon cancer
  • Gallstones
  • Hemorrhage
  • Intestinal strictures, perforation, and obstruction
  • Liver disease
  • Osteoporosis
  • Toxic megacolon

Possible Causes of Inflammatory Bowel Disease

The exact cause of IBD is not fully understood. It may occur in people with certain genetic traits when they encounter environmental factors that trigger an immune response, leading to inflammation in the intestines.

Some people with IBD have family members with the condition, and certain genetic markers may increase the likelihood of developing IBD. However, genetics alone do not determine whether someone will develop IBD; environmental factors also play a role.

Factors that have been studied in relation to IBD include sleep issues, stress, certain diets, medications, and exposure to environmental pollutants.

What Do Intestinal Inflammatory Biomarkers Tell You?

A colonoscopy is a common procedure to diagnose IBD, but it can be invasive. Inflammatory biomarkers can help determine if a colonoscopy is needed by indicating the presence of inflammation. These markers are often elevated in more serious conditions like IBD.

Traditionally, IBD severity and treatment response have been monitored through symptoms and imaging, but these methods can be costly and invasive. Biomarkers offer a non-invasive and cost-effective alternative for monitoring IBD.

No single biomarker can diagnose or monitor IBD perfectly, so a combination of different markers is often used to get a clearer picture of intestinal inflammation.

Top Functional Medicine Inflammatory Markers to Measure for Patients with IBD

Functional medicine labs can help healthcare providers understand and manage gastrointestinal disorders by measuring various inflammatory markers.

C-Reactive Protein (CRP)

CRP is a marker that can increase when there is inflammation in the body. It is not specific to IBD and can be elevated in other conditions as well. CRP is often used alongside other tests to help understand the presence and severity of inflammation.

Calprotectin

Calprotectin is a protein found in white blood cells, and its levels can rise in the stool of people with active IBD. It helps differentiate between IBD and other conditions like IBS.

Lactoferrin

Lactoferrin is another protein that can indicate inflammation in the intestines. It is used to help rule out non-inflammatory conditions and assess IBD activity.

Secretory IgA (sIgA)

sIgA is an antibody that helps protect the intestines from harmful substances. Elevated levels can indicate immune activity in the intestines.

Eosinophil Protein X (EPX)

EPX is released by certain white blood cells during inflammation. It can be elevated in conditions like allergies and IBD.

Lysozyme

Lysozyme is an enzyme that can be elevated in IBD, particularly in CD.

Interleukins

Interleukins are proteins that help regulate immune responses. They can be used to monitor IBD activity and are targets for some treatments.

Tumor Necrosis Factor Alpha (TNF-α)

TNF-α is involved in inflammation and can be used to monitor IBD. It is also a target for certain treatments.

Serum Amyloid A (SAA)

SAA is a protein that increases during inflammation and can help assess IBD severity.

[signup]

Summary

Managing IBD effectively involves accurate diagnosis and monitoring. While colonoscopy is a key tool, biomarkers provide a less invasive way to track disease activity and response to treatment. Using a combination of biomarkers can help guide treatment decisions and improve understanding of the condition.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

1. Cloyd, J. (2022, December 8). Inflammatory Bowel Disease: Treatments for IBD Flares and Remission. Rupa Health. https://www.rupahealth.com/post/inflammatory-bowel-disease-ibd-treatments-for-flares-and-remission

2. Henry, K. (2022, October 31). IBS vs IBD: Know The Symptoms. Rupa Health. https://www.rupahealth.com/post/ibs-vs-ibd-know-the-symptoms

3. McDowell, C., Farooq, U., & Haseeb, M. (2022). Inflammatory Bowel Disease. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470312/

4. Veauthier, B., & Hornecker, J.R. (2018b). Crohn's Disease: Diagnosis and Management. American Family Physician, 98(11), 661–669. https://www.aafp.org/pubs/afp/issues/2018/1201/p661.html

5. Lehmann, F.S., Burri, E., & Beglinger, C. (2015). The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology, 8(1), 23–36. https://doi.org/10.1177/1756283x14553384

6. Chen, P., Zhou, G., Lin, J., et al. (2020). Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine, 7. https://doi.org/10.3389/fmed.2020.00123

7. Mendoza, J.L., & Abreu, M. (2009). Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroenterologie Clinique Et Biologique, 33, S158–S173. https://doi.org/10.1016/s0399-8320(09)73151-3

8. Bourgonje, A.R., Von Martels, J.Z.H., Gabriëls, R.Y., et al. (2019). A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Frontiers in Medicine, 6. https://doi.org/10.3389/fmed.2019.00251

9. Gupta, M., Mishra, V., Gulati, M., et al. (2022). Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology, 30(2), 397–434. https://doi.org/10.1007/s10787-022-00931-1

10. Dragoni, G., Innocenti, T., & Galli, A. (2021). Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches? Digestive Diseases, 39(3), 190–203. https://doi.org/10.1159/000511641

11. Malani, S. (2023, February 2). Inflammatory Markers 101: How To Interpret. Rupa Health. https://www.rupahealth.com/post/inflammatory-markers-101-what-do-they-mean

12. Nakashige, T.G., Zhang, B., Krebs, C., et al. (2015). Human calprotectin is an iron-sequestering host-defense protein. Nature Chemical Biology, 11(10), 765–771. https://doi.org/10.1038/nchembio.1891

13. Dai, J., Liu, W., Zhao, Y., et al. (2007). Relationship between fecal lactoferrin and inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 42(12), 1440–1444. https://doi.org/10.1080/00365520701427094

14. Siddiqui, I., Majid, H., & Abid, S. (2017). Update on clinical and research application of fecal biomarkers for gastrointestinal diseases. World Journal of Gastrointestinal Pharmacology and Therapeutics, 8(1), 39. https://doi.org/10.4292/wjgpt.v8.i1.39

15. Dronfield, M.W., & Langman, M.J. (1975). Serum lysozyme in inflammatory bowel disease. Gut. https://doi.org/10.1136/gut.16.12.985

16. Malle, E., & De Beer, F.C. (1996). Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. European Journal of Clinical Investigation, 26(6), 427–435. https://doi.org/10.1046/j.1365-2362.1996.159291.x

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on GI Health
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.